Lipum strengthens the role of BSSL in rheumatoid arthritis

Lipum gears up with new CFO – one month into the assignment

Lipum has had a new CFO since September 1, Tobias Helgesson. With over 20 years of experience from senior roles, with...

Bioteknik
Intervju

Lipum | Investing in Life Science 2025

CEO Ola Sandborgh presents Lipum at Investing in Life Science 2025.

Video

Focus on preparation for Lipum during Q2

Lipum has published the Q2 report presenting several important achievements in 2025. Following the successful completion of the Phase I study, with...

Bioteknik
Intervju

Lipum appoints new CFO

Lipum reaches 89 percent subscription of warrants

Professor about the Lipum collaboration: “We want to be able to individualize treatment of RA”

Lipum is collaborating with Karolinska Institutet and Linköping University in a research project with the goal of identifying biomarkers that can predict...

Bioteknik
Intervju
RemeGen

Age Labs on the collaboration with Lipum: "We want to enable precision medicine in RA"

Lipum and Norwegian diagnostics company Age Labs are collaborating to develop a method to predict which patients with rheumatoid...

Flerie

Lipum looks towards phase II with Flerie at its back

Lipum

Lipum's COO on company building and entrepreneurship

Pernilla Abrahamsson has been COO at Lipum since 2019 and has since had a key role in the company's operations....

Intervju
Lipum

Chairman on Lipum's progress, vision and challenges

Ingemar Kihlström has been part of Lipum's board since 2021 and currently holds the role of chairman of the board. BioStock contacted...

Intervju
Lipum

Study goal reached – Lipum's CMO looks forward to the next chapter

Lipum has successfully completed the Phase I clinical study with positive results. The study confirms that the drug candidate SOL-116 is safe and...

Intervju